fda compounding glp-1 is moving to restrict mass-marketed compounded products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Compound versions of GLP-1 drugs

For most people, the effects last about one to two weeks, though the exact timeline shifts based on your current B12 levels, metabolism, diet, and how often you get injections

If a patient has an anaphylactic response to penicillins, cephalosporins should be avoided

Ridham Desai: And how do tariffs play into all this

Zalka is a 28 year long fellow of the American Academy of Dermatology, as well as the Dermatologic Surgery Society and the Connecticut State Dermatology and Dermatologic Surgery Society, where she also served as a past president

These established therapies have decades of clinical trial data demonstrating efficacy in reducing disease activity, preventing structural damage, and improving quality of life

Biologic Question An important regulatory subplot is Lilly's appeal of the FDA's classification of retatrutide